Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel EtG-Based Contingency Management for Alcohol in the Severely Mentally Ill

NCT01567943 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT01567943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01567943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel EtG-Based Contingency Management for Alcohol in the Severely Mentally Ill
Lead sponsor
University of Washington
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2012
Completion date
February 29, 2016
Enrollment
123 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abuse, bipolar disorder, major depressive disorder, schizophrenia